Phase II Trial of Anti-PD-1 Antibody Treatment and Radiotherapy in Early-stage Favorable Classic Hodgkin Lymphoma
Latest Information Update: 11 Apr 2025
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
- Acronyms PREFer
- 11 Apr 2025 New trial record